| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -200,719 | -201,484 |
| Net change in cash and cash equivalents, including cash classified within current assets held for sale | -202,863 | -212,235 |
| Less net change in cash classified within current assets held for sale | -32 | -54 |
| Net change in cash and cash equivalents | -202,895 | -212,289 |
| Cash and cash equivalents at beginning of period | 367,012 | - |
| Cash and cash equivalents at end of period | 164,117 | - |
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)